Overview

A Study of Ponesimod in Healthy Adult Participants Receiving Propranolol at Steady State

Status:
Completed
Trial end date:
2019-08-26
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the effect of the up-titration regimen of ponesimod on heart rate (HR) and other electrocardiogram (ECG) parameters when administrated to healthy adult participants receiving propranolol at steady state.
Phase:
Phase 1
Details
Lead Sponsor:
Janssen Pharmaceutica N.V., Belgium
Treatments:
Ponesimod
Propranolol